| pubmed-article:17577620 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17577620 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17577620 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17577620 | lifeskim:mentions | umls-concept:C0024623 | lld:lifeskim |
| pubmed-article:17577620 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:17577620 | lifeskim:mentions | umls-concept:C0069717 | lld:lifeskim |
| pubmed-article:17577620 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:17577620 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:17577620 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17577620 | pubmed:dateCreated | 2007-6-25 | lld:pubmed |
| pubmed-article:17577620 | pubmed:abstractText | In advanced gastric cancer few data are available on the efficacy or safety of new drug combination regimens after progression following first-line chemotherapy. | lld:pubmed |
| pubmed-article:17577620 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17577620 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577620 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17577620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17577620 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17577620 | pubmed:issn | 1436-3291 | lld:pubmed |
| pubmed-article:17577620 | pubmed:author | pubmed-author:CassanoAlessa... | lld:pubmed |
| pubmed-article:17577620 | pubmed:author | pubmed-author:SchinzariGiov... | lld:pubmed |
| pubmed-article:17577620 | pubmed:author | pubmed-author:QuirinoMichel... | lld:pubmed |
| pubmed-article:17577620 | pubmed:author | pubmed-author:BaroneCarloC | lld:pubmed |
| pubmed-article:17577620 | pubmed:author | pubmed-author:PozzoCarmeloC | lld:pubmed |
| pubmed-article:17577620 | pubmed:author | pubmed-author:BassoMicheleM | lld:pubmed |
| pubmed-article:17577620 | pubmed:author | pubmed-author:TrigilaNunzia... | lld:pubmed |
| pubmed-article:17577620 | pubmed:author | pubmed-author:D'ArgentoEtto... | lld:pubmed |
| pubmed-article:17577620 | pubmed:author | pubmed-author:AstoneAntonio... | lld:pubmed |
| pubmed-article:17577620 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17577620 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:17577620 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17577620 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17577620 | pubmed:pagination | 104-11 | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:meshHeading | pubmed-meshheading:17577620... | lld:pubmed |
| pubmed-article:17577620 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17577620 | pubmed:articleTitle | Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer. | lld:pubmed |
| pubmed-article:17577620 | pubmed:affiliation | Department of Medical Oncology, Università Cattolica del Sacro Cuore, Rome, Italy. | lld:pubmed |
| pubmed-article:17577620 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17577620 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
